Synergistic inhibition of cell proliferation by combined targeting with kinase inhibitors and dietary xanthone is a promising strategy for melanoma treatment.

MLA

Xia, Y., and J. Sun. “Synergistic Inhibition of Cell Proliferation by Combined Targeting with Kinase Inhibitors and Dietary Xanthone Is a Promising Strategy for Melanoma Treatment.” Clinical & Experimental Dermatology, vol. 43, no. 2, Mar. 2018, pp. 149–57. EBSCOhost, https://doi.org/10.1111/ced.13283.

APA

Xia, Y., & Sun, J. (2018). Synergistic inhibition of cell proliferation by combined targeting with kinase inhibitors and dietary xanthone is a promising strategy for melanoma treatment. Clinical & Experimental Dermatology, 43(2), 149–157. https://doi.org/10.1111/ced.13283

Chicago

Xia, Y., and J. Sun. 2018. “Synergistic Inhibition of Cell Proliferation by Combined Targeting with Kinase Inhibitors and Dietary Xanthone Is a Promising Strategy for Melanoma Treatment.” Clinical & Experimental Dermatology 43 (2): 149–57. doi:10.1111/ced.13283.